Lauren M Moore1, Sun Cho1, Katie L Thoren2. 1. Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 327 E. 64th St., New York, NY 10065, United States of America. 2. Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 327 E. 64th St., New York, NY 10065, United States of America. Electronic address: thorenk@mskcc.org.
Abstract
BACKGROUND: Daratumumab, a therapeutic IgG kappa monoclonal antibody, can cause a false positive interference on electrophoretic assays that are routinely used to monitor patients with monoclonal gammopathies. In this study, we evaluate the ability of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to distinguish daratumumab from disease-related IgG kappa monoclonal proteins (M-protein). METHODS: Waste clinical samples from 31 patients who were receiving daratumumab and had a history of IgG kappa monoclonal gammopathy were collected. Immunoglobulins were purified from serum and analyzed by MALDI-TOF MS. Mass spectra were assessed for the presence of distinct monoclonal proteins. For samples in which only one monoclonal peak was identified near the expected m/z of daratumumab, the Hydrashift 2/4 Daratumumab Assay was used to confirm the presence of an M-protein. RESULTS: Using MALDI-TOF MS, daratumumab could be distinguished from M-proteins in 26 out of 31 samples (84%). Results from 2 samples were inconclusive since the M-protein was not detected by the Hydrashift assay and may also be undetectable by MALDI-TOF MS. Comparatively, daratumumab was distinguishable from M-proteins in 14 out of 31 samples (45%) by immunofixation. CONCLUSIONS: MALDI-TOF MS offers greater specificity compared to immunofixation for distinguishing daratumumab from M-proteins.
BACKGROUND:Daratumumab, a therapeutic IgG kappa monoclonal antibody, can cause a false positive interference on electrophoretic assays that are routinely used to monitor patients with monoclonal gammopathies. In this study, we evaluate the ability of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to distinguish daratumumab from disease-related IgG kappa monoclonal proteins (M-protein). METHODS: Waste clinical samples from 31 patients who were receiving daratumumab and had a history of IgG kappa monoclonal gammopathy were collected. Immunoglobulins were purified from serum and analyzed by MALDI-TOF MS. Mass spectra were assessed for the presence of distinct monoclonal proteins. For samples in which only one monoclonal peak was identified near the expected m/z of daratumumab, the Hydrashift 2/4 Daratumumab Assay was used to confirm the presence of an M-protein. RESULTS: Using MALDI-TOF MS, daratumumab could be distinguished from M-proteins in 26 out of 31 samples (84%). Results from 2 samples were inconclusive since the M-protein was not detected by the Hydrashift assay and may also be undetectable by MALDI-TOF MS. Comparatively, daratumumab was distinguishable from M-proteins in 14 out of 31 samples (45%) by immunofixation. CONCLUSIONS: MALDI-TOF MS offers greater specificity compared to immunofixation for distinguishing daratumumab from M-proteins.
Authors: Christopher R McCudden; Peter M Voorhees; Shirley A Hainsworth; Herbert C Whinna; John F Chapman; Catherine A Hammett-Stabler; Monte S Willis Journal: Clin Chem Date: 2010-10-12 Impact factor: 8.327
Authors: John R Mills; Mindy C Kohlhagen; Maria A V Willrich; Taxiarchis Kourelis; Angela Dispenzieri; David L Murray Journal: Blood Date: 2018-06-11 Impact factor: 22.113
Authors: Christopher R McCudden; Joannes F M Jacobs; David Keren; Hélène Caillon; Thomas Dejoie; Kristian Andersen Journal: Clin Biochem Date: 2017-08-24 Impact factor: 3.281
Authors: María-Victoria Mateos; Meletios A Dimopoulos; Michele Cavo; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lucio; Zsolt Nagy; Polina Kaplan; Ludek Pour; Mark Cook; Sebastian Grosicki; Andre Crepaldi; Anna M Liberati; Philip Campbell; Tatiana Shelekhova; Sung-Soo Yoon; Genadi Iosava; Tomoaki Fujisaki; Mamta Garg; Christopher Chiu; Jianping Wang; Robin Carson; Wendy Crist; William Deraedt; Huong Nguyen; Ming Qi; Jesus San-Miguel Journal: N Engl J Med Date: 2017-12-12 Impact factor: 91.245
Authors: Paolo Milani; David L Murray; David R Barnidge; Mindy C Kohlhagen; John R Mills; Giampaolo Merlini; Surendra Dasari; Angela Dispenzieri Journal: Am J Hematol Date: 2017-06-01 Impact factor: 10.047
Authors: Kazunori Murata; Samuel I McCash; Brittany Carroll; Alexander M Lesokhin; Hani Hassoun; Nikoletta Lendvai; Neha S Korde; Sham Mailankody; Heather J Landau; Guenther Koehne; David J Chung; Sergio A Giralt; Lakshmi V Ramanathan; Ola Landgren Journal: Clin Biochem Date: 2016-09-21 Impact factor: 3.281
Authors: John R Mills; Mindy C Kohlhagen; Surendra Dasari; Patrick M Vanderboom; Robert A Kyle; Jerry A Katzmann; Maria A V Willrich; David R Barnidge; Angela Dispenzieri; David L Murray Journal: Clin Chem Date: 2016-08-18 Impact factor: 8.327
Authors: Maria Alice V Willrich; Paula M Ladwig; Bruna D Andreguetto; David R Barnidge; David L Murray; Jerry A Katzmann; Melissa R Snyder Journal: Clin Chem Lab Med Date: 2016-06-01 Impact factor: 3.694
Authors: Nina Shah; Jack Aiello; David E Avigan; Jesus G Berdeja; Ivan M Borrello; Ajai Chari; Adam D Cohen; Karthik Ganapathi; Lissa Gray; Damian Green; Amrita Krishnan; Yi Lin; Elisabet Manasanch; Nikhil C Munshi; Ajay K Nooka; Aaron P Rapoport; Eric L Smith; Ravi Vij; Madhav Dhodapkar Journal: J Immunother Cancer Date: 2020-07 Impact factor: 13.751
Authors: Rasa Santockyte; Chelsea Jin; James Pratt; Ron Ammar; Keyur Desai; Mohan Bolisetty; Prianka Das; Mihaela Popa-McKiver; Oscar Puig Journal: Blood Cancer J Date: 2021-04-29 Impact factor: 11.037
Authors: Paolo Milani; Marco Basset; Mario Nuvolone; Francesca Benigna; Lara Rodigari; Francesca Lavatelli; Andrea Foli; Giampaolo Merlini; Giovanni Palladini Journal: Blood Cancer J Date: 2020-09-01 Impact factor: 11.037
Authors: David L Murray; Noemi Puig; Sigurdur Kristinsson; Saad Z Usmani; Angela Dispenzieri; Giada Bianchi; Shaji Kumar; Wee Joo Chng; Roman Hajek; Bruno Paiva; Anders Waage; S Vincent Rajkumar; Brian Durie Journal: Blood Cancer J Date: 2021-02-01 Impact factor: 11.037